These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8967073)

  • 21. Role of serum neutralizing antibody in reinfection of respiratory syncytial virus.
    Kawasaki Y; Hosoya M; Katayose M; Suzuki H
    Pediatr Int; 2004 Apr; 46(2):126-9. PubMed ID: 15056236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment.
    Domachowske JB; Rosenberg HF
    Clin Microbiol Rev; 1999 Apr; 12(2):298-309. PubMed ID: 10194461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for admission and the role of respiratory syncytial virus-specific cytotoxic T-lymphocyte responses in children with acute bronchiolitis.
    Jeena PM; Ayannusi OE; Annamalai K; Naidoo P; Coovadia HM; Guldner P
    S Afr Med J; 2003 Apr; 93(4):291-4. PubMed ID: 12806723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease.
    Cortjens B; de Boer OJ; de Jong R; Antonis AF; Sabogal Piñeros YS; Lutter R; van Woensel JB; Bem RA
    J Pathol; 2016 Feb; 238(3):401-11. PubMed ID: 26468056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge.
    Fischer JE; Johnson TR; Peebles RS; Graham BS
    J Infect Dis; 1999 Sep; 180(3):714-9. PubMed ID: 10438359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay.
    Do LAH; Tse R; Nathanielsz J; Anderson J; Ong DS; Chappell K; Mulholland K; Licciardi PV
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30741261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Respiratory syncytial virus infection in hospitalized patients and healthy children in El Salvador.
    Colocho Zelaya EA; Pettersson CA; Forsgren M; Orvell C; Strannegard O
    Am J Trop Med Hyg; 1994 Nov; 51(5):577-84. PubMed ID: 7985749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis.
    Harcourt JL; Karron RA; Tripp RA
    J Infect Dis; 2004 Dec; 190(11):1936-40. PubMed ID: 15529257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH; Gong W; Fang XP; Zhang ZY; Mei XG
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):534-9. PubMed ID: 16176088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
    J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secretory IgM and IgA antibodies to respiratory syncytial virus in nasopharyngeal aspirates: a diagnostic supplement to antigen detection.
    Jensen IP; Thisted E; Glikmann G; Obel N; Kofoed PE; Sambo M; Valerius NH; Mordhorst CH
    Clin Diagn Virol; 1997 Nov; 8(3):219-26. PubMed ID: 9406652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.
    Falsey AR; Formica MA; Hennessey PA; Criddle MM; Sullender WM; Walsh EE
    Am J Respir Crit Care Med; 2006 Mar; 173(6):639-43. PubMed ID: 16387798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.
    Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB
    Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein.
    Elliott MB; Pryharski KS; Yu Q; Boutilier LA; Campeol N; Melville K; Laughlin TS; Gupta CK; Lerch RA; Randolph VB; LaPierre NA; Dack KM; Hancock GE
    J Virol; 2004 Aug; 78(16):8446-54. PubMed ID: 15280453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indices of local antiviral immunity in patients with chronic bronchitis].
    Makhovenko LV; Shefer LF
    Ter Arkh; 1988; 60(11):95-7. PubMed ID: 2853456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.